Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-08-19The Gut Metagenome Research of Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-08-18ClinicalTrials.gov study NCT03000985
-
CLINICAL_TRIALS study record update · 2021-08-17Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation
-
CLINICAL_TRIALS study record update · 2021-08-16Pharmacologic Augmentation of Neurocognition and Cognitive Training in Psychosis
-
CLINICAL_TRIALS study record update · 2021-08-13Atypical Antipsychotics and P50 Sensory Gating
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-08-12Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
-
CLINICAL_TRIALS study record update · 2021-08-11Evaluation of mHealth for Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2021-08-10Enhancing Social Functioning in Schizophrenia Through Scalable Mobile Technology
-
CLINICAL_TRIALS study record update · 2021-08-09Retinoic Acid Homeostasis in Neuropsychiatric Diseases
-
CLINICAL_TRIALS study record update · 2021-08-04Cognitive Behaviour Therapy for Voices and Dissociation: A Case Series
-
CLINICAL_TRIALS study record update · 2021-08-03Comparison of Three Different Exercise Training Modalities (Aerobic, Strength, and Mixed) in Patients With Schizophrenia: Study Protocol for a Multi-centre Randomised Wait-list Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-07-28Remote Physiological, Behavioral and Symptom Assessment Study to Identify Predictors of Symptom Exacerbation and Relapse in Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-07-27A Double-Blind Placebo-Controlled Trial of a Sulforaphane Nutraceutical to Reduce the Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-07-26Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
-
CLINICAL_TRIALS study record update · 2021-07-26Gut Microbiome and Metabolic Dysfunction in Antipsychotic Naïve Patients
-
CLINICAL_TRIALS study record update · 2021-07-23A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine
-
CLINICAL_TRIALS study record update · 2021-07-21A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-07-21Cognitive Remediation for Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-07-13Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-07-13Improving Visual Attention to Social Stimuli in Individuals With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-07-08Remediation of Auditory Recognition in Schizophrenia With Transcranial Direct Current Stimulation (tDCS)
-
CLINICAL_TRIALS study record update · 2021-07-07A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS) in Smokers
-
CLINICAL_TRIALS study record update · 2021-07-07An Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of 180 mg Risperidone Subcutaneous Injection (PERSERIS) Following a Switch From 6 mg Oral Risperidone in Patients With Clinically Stable Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-07-07A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS) in Nonsmokers
-
CLINICAL_TRIALS study record update · 2021-07-02A Phase 1B Trial To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of CVL-231 in Subjects With Schizophrenia